Morgan Stanley’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Buy |
|
|||||
|
2025
Q1 | $3.19M | Sell |
|
|||||
|
2024
Q4 | $2.89M | Buy |
|
|||||
|
2024
Q3 | $2.81M | Buy |
|
|||||
|
2024
Q2 | $1.03M | Sell |
|
|||||
|
2024
Q1 | $1.14M | Sell |
|
|||||
|
2023
Q4 | $2.95M | Buy |
|
|||||
|
2023
Q3 | $1.66M | Sell |
|
|||||
|
2023
Q2 | $2.69M | Sell |
|
|||||
|
2023
Q1 | $11.7M | Buy |
|
|||||
|
2022
Q4 | $2.19M | Buy |
|
|||||
|
2022
Q3 | $1.62M | Sell |
|
|||||
|
2022
Q2 | $1.46M | Buy |
|
|||||
|
2022
Q1 | $1.57M | Buy |
|
|||||
|
2021
Q4 | $693K | Buy |
|
|||||
|
2021
Q3 | $483K | Sell |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $194K | Buy |
|
|||||
|
2020
Q4 | $87K | Buy |
|
|||||
|
2020
Q3 | $40K | Sell |
|
|||||
|
2020
Q2 | $908K | Buy |
|
|||||
|
2020
Q1 | $4K | Sell |
|
|||||
|
2019
Q4 | $191K | Buy |
|
|||||
|
2019
Q3 | $50K | Buy |
|
|||||
|
2019
Q2 | $14K | Sell |
|
|||||
|
2019
Q1 | $53K | Sell |
|
|||||
|
2018
Q4 | $279K | Sell |
|
|||||
|
2018
Q3 | $500K | Sell |
|
|||||
|
2018
Q2 | $340K | Buy |
|
|||||
|
2018
Q1 | $111K | Buy |
|
|||||
|
2017
Q4 | $69K | Buy |
|
|||||
|
2017
Q3 | $71K | Buy |
|
|||||
|
2017
Q2 | $13K | Buy |
|
|||||
|
2017
Q1 | $14K | Sell |
|
|||||
|
2016
Q4 | $16K | Sell |
|
|||||
|
2016
Q3 | $35K | Buy |
|
|||||
|
2016
Q2 | $22K | Buy |
|
|||||
|
2016
Q1 | $15K | Sell |
|
|||||
|
2015
Q4 | $49K | Sell |
|
|||||
|
2015
Q3 | $119K | Buy |
|
|||||
|
2015
Q2 | $128K | Buy |
|
|||||
|
2015
Q1 | $141K | Buy |
|
|||||
|
2014
Q4 | $9K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $0 | Buy |
|